Stephen Thomas
Directeur/Membre du Conseil chez ELIEM THERAPEUTICS, INC.
Fortune : 801 123 $ au 31/05/2024
Profil
Stephen Thomas is the founder of Ichorion Therapeutics, Inc. which was founded in 2017.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ELIEM THERAPEUTICS, INC.
0,36% | 27/06/2024 | 103 907 ( 0,36% ) | 801 123 $ | 31/05/2024 |
Postes actifs de Stephen Thomas
| Sociétés | Poste | Début |
|---|---|---|
| ELIEM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/06/2024 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Fondateur | 07/07/2017 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
